EUVIMEDEUVIMED entdecken
Crossref

Microfluidic single-cell drug screening: toward personalized precision therapy in chronic myeloid leukemia

Hwisu Jeon iD, Yukyung Park iD, Soo-Hyun Kim iD, Chang-Yeol Jung, Hongtae Kim, Eujin Um iD, Dong-Wook Kim iD, Taesung Kim iD

Lab on a Chip · 2025

DOI: 10.1039/d5lc00779h ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lab on a Chip, 2025. Verfasst von Hwisu Jeon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, Ulsan National Institute of Science and Technology (UNIST), 50 UNIST-Gil, Ulsan 44919, Republic of Korea. tskim…. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Single-Cell Analysis, Protein Kinase Inhibitors, Precision Medicine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Ministry of Trade, Industry and Energy, Ministry of SMEs and Startups.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We developed a fully integrated microfluidic drug screening platform, combining centrifugal cell loading, automated flow control, and single-cell-resolution image analysis to enable quantitative, patient-specific therapeutic assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveSingle-Cell AnalysisProtein Kinase InhibitorsPrecision MedicineAntineoplastic AgentsMicrofluidic Analytical TechniquesLab-On-A-Chip DevicesHumansFusion Proteins, bcr-ablDrug Screening Assays, AntitumorK562 CellsCell Line, TumorCell Survival

Substanzen

Protein Kinase InhibitorsFusion Proteins, bcr-ablAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Mechanical Engineering, Ulsan National Institute of Science and Technology (UNIST), 50 UNIST-Gil, Ulsan 44919, Republic of Korea. tskim@unist.ac.kr.
  • TKMS, Inc., 50 UNIST-Gil, Ulsan 44919, Republic of Korea.
  • Department of Hematology, Hematology Center, Uijeongbu Eulji Medical Center, Eulji University, 712 Dong-il-Ro, Uijeongbu-Si, Gyeonggi-Do 11749, Republic of Korea. dwkim@eulji.ac.kr.
  • Leukemia Omics Research Institute, Eulji University Uijeongbu Campus, 712 Dong-il-Ro, Uijeongbu-Si, Gyeonggi-Do, 11749, Republic of Korea.
  • Department of Mathematical Sciences, Ulsan National Institute of Science and Technology (UNIST), 50 UNIST-Gil, Ulsan 44919, Republic of Korea.
  • Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), 50 UNIST-Gil, Ulsan 44919, Republic of Korea.

ORCID-Profile: Hwisu Jeon, Yukyung Park, Soo-Hyun Kim, Eujin Um, Dong-Wook Kim, Taesung Kim

Förderung

  • Ministry of Trade, Industry and Energy
  • Ministry of SMEs and Startups

Zitieren

APA

Jeon, H., Park, Y., Kim, S. H., Jung, C. Y., Kim, H., Um, E., Kim, D. W., & Kim, T. (2025). Microfluidic single-cell drug screening: toward personalized precision therapy in chronic myeloid leukemia. Lab on a Chip. https://doi.org/10.1039/d5lc00779h

Vancouver

Jeon H, Park Y, Kim SH, Jung CY, Kim H, Um E, et al. Microfluidic single-cell drug screening: toward personalized precision therapy in chronic myeloid leukemia. Lab on a Chip. 2025. doi:10.1039/d5lc00779h

BibTeX
@article{Jeon2025,
  author = {Jeon, Hwisu and Park, Yukyung and Kim, Soo-Hyun and Jung, Chang-Yeol and Kim, Hongtae and Um, Eujin and Kim, Dong-Wook and Kim, Taesung},
  title = {Microfluidic single-cell drug screening: toward personalized precision therapy in chronic myeloid leukemia},
  journal = {Lab on a Chip},
  year = {2025},
  doi = {10.1039/d5lc00779h}
}
Kostenlos starten →